CJC/IPA (6/4mg) Blend: Product Description
The CJC-1295/Ipamorelin blend combines two chemically distinct research peptides investigated through complementary growth-hormone-associated signaling pathways. CJC-1295 No DAC, commonly identified as Modified GRF 1-29, is a synthetic analog of growth hormone-releasing hormone. Ipamorelin is a synthetic pentapeptide investigated as an agonist of the growth hormone secretagogue receptor, also known as the ghrelin receptor.
Controlled laboratory research involving this blend may examine GHRH-receptor activity, growth hormone secretagogue receptor interactions, intracellular signaling and communication between two separate receptor systems. Experimental models may also evaluate receptor selectivity, peptide stability and the influence of different component ratios on observed cellular responses.
Each component retains its individual molecular identity. Therefore, the blend does not have one unified molecular formula, molecular weight or CAS number. The distinction between CJC-1295 with DAC and CJC-1295 No DAC is particularly important because they are structurally different research materials. The specifications below correspond to the No DAC version and should be verified against the product's Certificate of Analysis.
The 6/4 mg presentation contains 6 mg of CJC-1295 No DAC and 4 mg of Ipamorelin, for a total nominal peptide content of 10 mg. Identity, component quantity, purity and chemical form should be confirmed through the batch-specific Certificate of Analysis.
Research Specifications
CJC-1295 No DAC: 6 mg
Molecular Formula: C152H252N44O42
Molecular Weight: Approximately 3,367.9 g/mol
Compound Type: Modified GHRH 1-29 analog
Research Target: GHRH receptor
Required Verification: No DAC identity and chemical form on COA
Ipamorelin: 4 mg
Molecular Formula: C38H49N9O5
Molecular Weight: Approximately 711.85 g/mol
CAS Number: 170851-70-4
Amino Acid Count: 5
Compound Type: Synthetic growth hormone secretagogue
Research Target: Growth hormone secretagogue/ghrelin receptor
Total Presentation: 10 mg
Blend Ratio: 6 mg CJC-1295 No DAC / 4 mg Ipamorelin
FOR RESEARCH USE ONLY. NOT FOR HUMAN OR ANIMAL CONSUMPTION. NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE.






Reviews
There are no reviews yet.